Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Peter C. Black, Beatrix Palmer-Aronsten et al.|European Urology|2017Cited by 793
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Peter C. Black, Ewan A. Gibb et al.|Clinical Cancer Research|2018Cited by 126
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J. de Jong, Ewan A. Gibb, Yang Liu et al.|Genome Medicine|2019Cited by 102
CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic responseRoland Seiler, Achim Fleischmann|Modern Pathology|2013Cited by 94
Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelinesBernd J. Schmitz‐Dräger, Lambertus A. Kiemeney, Eva Charlotte Kuckuck et al.|Urologic Oncology Seminars and Original Investigations|2016Cited by 33